Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02910453

NCT02910453
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • The lung tumor must not be located too close to major airways or blood vessels in the lung, based on a CT scan
  • You must have a type of lung cancer called Non-Small Cell Lung Cancer, at an early to moderate stage that has not spread far (stages T1-2, N0 or N1, M0)
  • You must be healthy enough to be put under general anesthesia and to have a surgical procedure that removes a large section of the lung (called a lobectomy)

Who may not be able to join:

  • You have had previous surgery on the same side of the chest before
  • Your surgical plan involves removing a smaller segment of the lung or the entire lung
  • You have any kind of ongoing chronic pain that requires you to take pain medication every day
  • Your Body Mass Index (BMI) is 35 or higher (confirm with trial site if you are unsure of your BMI)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Registry
clinicaltrials_gov
Start date
1 January 2015
Est. completion
1 October 2015

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Modification of respiratory kinematic

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov